Stephan Buch

Dresden, SN, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

The landscape of artificial intelligence-enabled medical devices in the EU and the US intended for intensive care units.

The landscape of artificial intelligence-enabled medical devices in the EU and the US intended for intensive care units.

Journal: NPJ digital medicine

Published: January 10, 2026

The regulation of artificial intelligence in intensive care units: from narrow tools to generalist systems.

The regulation of artificial intelligence in intensive care units: from narrow tools to generalist systems.

Journal: NPJ digital medicine

Published: July 14, 2025

Meta-Analysis: Effects of Steatotic Liver Disease-Associated Genetic Risk Alleles on Longitudinal Outcomes.

Meta-Analysis: Effects of Steatotic Liver Disease-Associated Genetic Risk Alleles on Longitudinal Outcomes.

Journal: Alimentary pharmacology & therapeutics

Published: March 28, 2025

PNPLA3 in Alcohol-Related Liver Disease.

PNPLA3 in Alcohol-Related Liver Disease.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: November 18, 2024

Interpreting elevated liver blood test results through a genetic lens: A genome-wide association study.

Interpreting elevated liver blood test results through a genetic lens: A genome-wide association study.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: June 21, 2024

The rs72613567:TA polymorphism in HSD17B13 is associated with survival benefit after development of hepatocellular carcinoma.

The rs72613567:TA polymorphism in HSD17B13 is associated with survival benefit after development of hepatocellular carcinoma.

Journal: Alimentary pharmacology & therapeutics

Published: March 02, 2023

Genetic Variation of SAMM50 Is Not an Independent Risk Factor for Alcoholic Hepatocellular Carcinoma in Caucasian Patients.

Genetic Variation of SAMM50 Is Not an Independent Risk Factor for Alcoholic Hepatocellular Carcinoma in Caucasian Patients.

Journal: International journal of molecular sciences

Published: November 02, 2022

High producer variant of lipoprotein lipase may protect from hepatocellular carcinoma in alcohol-associated cirrhosis.

High producer variant of lipoprotein lipase may protect from hepatocellular carcinoma in alcohol-associated cirrhosis.

Journal: JHEP reports : innovation in hepatology

Published: August 15, 2022

Genetic variation in TERT modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study.

Genetic variation in TERT modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study.

Journal: Gut

Published: February 15, 2022

Performance of routine risk scores for predicting cirrhosis-related morbidity in the community.

Performance of routine risk scores for predicting cirrhosis-related morbidity in the community.

Journal: Journal of hepatology

Published: November 02, 2021

The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With Cirrhosis.

The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With Cirrhosis.

Journal: Hepatology communications

Published: September 01, 2021

PSD3 downregulation confers protection against fatty liver disease.

PSD3 downregulation confers protection against fatty liver disease.

Journal: Nature metabolism

Published: August 23, 2021

Showing 1-12 of 53

Last Updated: 09/26/2026